First Time Loading...

Synaptogenix Inc
NASDAQ:SNPX

Watchlist Manager
Synaptogenix Inc Logo
Synaptogenix Inc
NASDAQ:SNPX
Watchlist
Price: 4.83 USD -0.21% Market Closed
Updated: May 22, 2024

Intrinsic Value

SNPX doesn't have a meaningful market cap.
SNPX's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

Synaptogenix, Inc. operates as a biopharmaceutical company. [ Read More ]

The intrinsic value of one SNPX stock under the Base Case scenario is 26.81 USD. Compared to the current market price of 4.83 USD, Synaptogenix Inc is Undervalued by 82%.

Key Points:
SNPX Intrinsic Value
Base Case
26.81 USD
Undervaluation 82%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Synaptogenix Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling SNPX stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Synaptogenix Inc

Provide an overview of the primary business activities
of Synaptogenix Inc.

What unique competitive advantages
does Synaptogenix Inc hold over its rivals?

What risks and challenges
does Synaptogenix Inc face in the near future?

Has there been any significant insider trading activity
in Synaptogenix Inc recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Synaptogenix Inc.

Provide P/S
for Synaptogenix Inc.

Provide P/E
for Synaptogenix Inc.

Provide P/OCF
for Synaptogenix Inc.

Provide P/FCFE
for Synaptogenix Inc.

Provide P/B
for Synaptogenix Inc.

Provide EV/S
for Synaptogenix Inc.

Provide EV/GP
for Synaptogenix Inc.

Provide EV/EBITDA
for Synaptogenix Inc.

Provide EV/EBIT
for Synaptogenix Inc.

Provide EV/OCF
for Synaptogenix Inc.

Provide EV/FCFF
for Synaptogenix Inc.

Provide EV/IC
for Synaptogenix Inc.

Show me price targets
for Synaptogenix Inc made by professional analysts.

What are the Revenue projections
for Synaptogenix Inc?

How accurate were the past Revenue estimates
for Synaptogenix Inc?

What are the Net Income projections
for Synaptogenix Inc?

How accurate were the past Net Income estimates
for Synaptogenix Inc?

What are the EPS projections
for Synaptogenix Inc?

How accurate were the past EPS estimates
for Synaptogenix Inc?

What are the EBIT projections
for Synaptogenix Inc?

How accurate were the past EBIT estimates
for Synaptogenix Inc?

Compare the revenue forecasts
for Synaptogenix Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Synaptogenix Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Synaptogenix Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Synaptogenix Inc compared to its peers.

Compare the P/E ratios
of Synaptogenix Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Synaptogenix Inc with its peers.

Analyze the financial leverage
of Synaptogenix Inc compared to its main competitors.

Show all profitability ratios
for Synaptogenix Inc.

Provide ROE
for Synaptogenix Inc.

Provide ROA
for Synaptogenix Inc.

Provide ROIC
for Synaptogenix Inc.

Provide ROCE
for Synaptogenix Inc.

Provide Gross Margin
for Synaptogenix Inc.

Provide Operating Margin
for Synaptogenix Inc.

Provide Net Margin
for Synaptogenix Inc.

Provide FCF Margin
for Synaptogenix Inc.

Show all solvency ratios
for Synaptogenix Inc.

Provide D/E Ratio
for Synaptogenix Inc.

Provide D/A Ratio
for Synaptogenix Inc.

Provide Interest Coverage Ratio
for Synaptogenix Inc.

Provide Altman Z-Score Ratio
for Synaptogenix Inc.

Provide Quick Ratio
for Synaptogenix Inc.

Provide Current Ratio
for Synaptogenix Inc.

Provide Cash Ratio
for Synaptogenix Inc.

What is the historical Revenue growth
over the last 5 years for Synaptogenix Inc?

What is the historical Net Income growth
over the last 5 years for Synaptogenix Inc?

What is the current Free Cash Flow
of Synaptogenix Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Synaptogenix Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Synaptogenix Inc

Current Assets 30.5m
Cash & Short-Term Investments 28.7m
Other Current Assets 1.9m
Non-Current Assets 580.9k
Long-Term Investments 562.4k
PP&E 18.5k
Current Liabilities 4.3m
Accounts Payable 444.6k
Accrued Liabilities 3.8m
Non-Current Liabilities 1.3m
Other Non-Current Liabilities 1.3m
Efficiency

Earnings Waterfall
Synaptogenix Inc

Revenue
0 USD
Operating Expenses
-8.3m USD
Operating Income
-8.3m USD
Other Expenses
-5.5m USD
Net Income
-13.8m USD

Free Cash Flow Analysis
Synaptogenix Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

SNPX Profitability Score
Profitability Due Diligence

Synaptogenix Inc's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

31/100
Profitability
Score

Synaptogenix Inc's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

SNPX Solvency Score
Solvency Due Diligence

Synaptogenix Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
61/100
Solvency
Score

Synaptogenix Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SNPX Price Targets Summary
Synaptogenix Inc

Wall Street analysts forecast SNPX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SNPX is 14 USD .

Lowest
Price Target
Not Available
Average
Price Target
14 USD
190% Upside
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Competitors Analysis
Synaptogenix Inc

Ownership

SNPX Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

SNPX Price
Synaptogenix Inc

1M 1M
+11%
6M 6M
+1 689%
1Y 1Y
+462%
3Y 3Y
-32%
5Y 5Y
+40%
10Y 10Y
+40%
Annual Price Range
4.83
52w Low
0.1586
52w High
5.39
Price Metrics
Average Annual Return 10.63%
Standard Deviation of Annual Returns 83.84%
Max Drawdown -99%
Shares Statistics
Market Capitalization 5.3m USD
Shares Outstanding 1 090 000
Percentage of Shares Shorted 2.81%

SNPX Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Synaptogenix Inc Logo
Synaptogenix Inc

Country

United States of America

Industry

Biotechnology

Market Cap

5.3m USD

Dividend Yield

0%

Description

Synaptogenix, Inc. operates as a biopharmaceutical company. The company is headquartered in New York City, New York and currently employs 4 full-time employees. The company went IPO on 2020-12-07. The firm is principally focused on developing therapeutics for patients with neurodegenerative diseases and developmental disorders. The firm is developing a product platform based upon a drug candidate called Bryostatin-1, which is synthesized from a natural product (bryostatin) that is isolated from a marine invertebrate organism, for the treatment of Alzheimer’s disease (AD). Its lead product candidate is bryostatin-1. Bryostatin-1 is a Protein Kinase C Epsilon (PKC e), a and e activator that was originally developed as a potential anticancer drug. The firm is also evaluating therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing.

Contact

NEW YORK
New York City
1185 Avenue Of The Americas, 3Rd Floor
+19732420005.0
https://www.synaptogen.com/

IPO

2020-12-07

Employees

4

Officers

CEO & Director
Dr. Alan J. Tuchman M.D., MBA(FAAN)
President, Chief Scientific Officer & Director
Dr. Daniel L. Alkon M.D.
CFO, Executive VP, Treasurer & Secretary
Mr. Robert Weinstein

See Also

Discover More
What is the Intrinsic Value of one SNPX stock?

The intrinsic value of one SNPX stock under the Base Case scenario is 26.81 USD.

Is SNPX stock undervalued or overvalued?

Compared to the current market price of 4.83 USD, Synaptogenix Inc is Undervalued by 82%.